nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—OPRK1—GPCR ligand binding—CCL27—atopic dermatitis	0.00146	0.00515	CbGpPWpGaD
Nalbuphine—Sweating increased—Methylprednisolone—atopic dermatitis	0.00146	0.00204	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00146	0.00512	CbGpPWpGaD
Nalbuphine—Oedema—Tacrolimus—atopic dermatitis	0.00145	0.00203	CcSEcCtD
Nalbuphine—Abdominal pain—Mometasone—atopic dermatitis	0.00144	0.00202	CcSEcCtD
Nalbuphine—Body temperature increased—Mometasone—atopic dermatitis	0.00144	0.00202	CcSEcCtD
Nalbuphine—Shock—Tacrolimus—atopic dermatitis	0.00143	0.002	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00143	0.00502	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00142	0.00501	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00142	0.005	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00142	0.00499	CbGpPWpGaD
Nalbuphine—Tachycardia—Tacrolimus—atopic dermatitis	0.00142	0.00198	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00141	0.00197	CcSEcCtD
Nalbuphine—Dizziness—Loratadine—atopic dermatitis	0.00141	0.00196	CcSEcCtD
Nalbuphine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.0014	0.00196	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00139	0.00489	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.00139	0.00488	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00136	0.00479	CbGpPWpGaD
Nalbuphine—Hypotension—Tacrolimus—atopic dermatitis	0.00136	0.0019	CcSEcCtD
Nalbuphine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00135	0.00189	CcSEcCtD
Nalbuphine—Vomiting—Loratadine—atopic dermatitis	0.00135	0.00189	CcSEcCtD
Nalbuphine—Rash—Loratadine—atopic dermatitis	0.00134	0.00187	CcSEcCtD
Nalbuphine—Dermatitis—Loratadine—atopic dermatitis	0.00134	0.00187	CcSEcCtD
Nalbuphine—Headache—Loratadine—atopic dermatitis	0.00133	0.00186	CcSEcCtD
Nalbuphine—Bradycardia—Prednisolone—atopic dermatitis	0.00133	0.00186	CcSEcCtD
Nalbuphine—Sweating increased—Dexamethasone—atopic dermatitis	0.00133	0.00185	CcSEcCtD
Nalbuphine—Sweating increased—Betamethasone—atopic dermatitis	0.00133	0.00185	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00132	0.00465	CbGpPWpGaD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00132	0.00464	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.00131	0.00462	CbGpPWpGaD
Nalbuphine—Asthenia—Mometasone—atopic dermatitis	0.00131	0.00183	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—atopic dermatitis	0.0013	0.00182	CcSEcCtD
Nalbuphine—Paraesthesia—Tacrolimus—atopic dermatitis	0.0013	0.00182	CcSEcCtD
Nalbuphine—Bradycardia—Hydrocortisone—atopic dermatitis	0.0013	0.00181	CcSEcCtD
Nalbuphine—Dyspnoea—Tacrolimus—atopic dermatitis	0.00129	0.00181	CcSEcCtD
Nalbuphine—Somnolence—Tacrolimus—atopic dermatitis	0.00129	0.0018	CcSEcCtD
Nalbuphine—Pruritus—Mometasone—atopic dermatitis	0.00129	0.0018	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00129	0.00454	CbGpPWpGaD
Nalbuphine—Dyspepsia—Tacrolimus—atopic dermatitis	0.00128	0.00179	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00127	0.00447	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00127	0.00447	CbGpPWpGaD
Nalbuphine—Hallucination—Hydrocortisone—atopic dermatitis	0.00127	0.00177	CcSEcCtD
Nalbuphine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00126	0.00177	CcSEcCtD
Nalbuphine—Nausea—Loratadine—atopic dermatitis	0.00126	0.00176	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00125	0.00439	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00124	0.00438	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.00124	0.00435	CbGpPWpGaD
Nalbuphine—Bradycardia—Triamcinolone—atopic dermatitis	0.00122	0.00171	CcSEcCtD
Nalbuphine—Bradycardia—Methylprednisolone—atopic dermatitis	0.00122	0.0017	CcSEcCtD
Nalbuphine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00122	0.0017	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.00121	0.00424	CbGpPWpGaD
Nalbuphine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.00168	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.0012	0.00424	CbGpPWpGaD
Nalbuphine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.00168	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.0012	0.00423	CbGpPWpGaD
Nalbuphine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.00167	CcSEcCtD
Nalbuphine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.0012	0.00167	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00119	0.0042	CbGpPWpGaD
Nalbuphine—Hallucination—Methylprednisolone—atopic dermatitis	0.00119	0.00167	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00119	0.00166	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00117	0.00413	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00117	0.00412	CbGpPWpGaD
Nalbuphine—Vomiting—Mometasone—atopic dermatitis	0.00116	0.00162	CcSEcCtD
Nalbuphine—Sweating increased—Prednisone—atopic dermatitis	0.00115	0.00161	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00115	0.00406	CbGpPWpGaD
Nalbuphine—Urticaria—Tacrolimus—atopic dermatitis	0.00115	0.00161	CcSEcCtD
Nalbuphine—Rash—Mometasone—atopic dermatitis	0.00115	0.00161	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00115	0.00405	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00115	0.00405	CbGpPWpGaD
Nalbuphine—Dermatitis—Mometasone—atopic dermatitis	0.00115	0.00161	CcSEcCtD
Nalbuphine—Abdominal pain—Tacrolimus—atopic dermatitis	0.00115	0.0016	CcSEcCtD
Nalbuphine—Body temperature increased—Tacrolimus—atopic dermatitis	0.00115	0.0016	CcSEcCtD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00115	0.00404	CbGpPWpGaD
Nalbuphine—Headache—Mometasone—atopic dermatitis	0.00114	0.0016	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—atopic dermatitis	0.00114	0.00159	CcSEcCtD
Nalbuphine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00114	0.00159	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00113	0.00398	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00113	0.00397	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00112	0.00393	CbGpPWpGaD
Nalbuphine—Erythema—Hydrocortisone—atopic dermatitis	0.00111	0.00155	CcSEcCtD
Nalbuphine—Bradycardia—Dexamethasone—atopic dermatitis	0.00111	0.00155	CcSEcCtD
Nalbuphine—Bradycardia—Betamethasone—atopic dermatitis	0.00111	0.00155	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.00111	0.0039	CbGpPWpGaD
Nalbuphine—Hallucination—Betamethasone—atopic dermatitis	0.00108	0.00151	CcSEcCtD
Nalbuphine—Hallucination—Dexamethasone—atopic dermatitis	0.00108	0.00151	CcSEcCtD
Nalbuphine—Nausea—Mometasone—atopic dermatitis	0.00108	0.00151	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—atopic dermatitis	0.00107	0.0015	CcSEcCtD
Nalbuphine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00107	0.00149	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.00106	0.00372	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00105	0.00371	CbGpPWpGaD
Nalbuphine—Depression—Prednisone—atopic dermatitis	0.00105	0.00147	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00105	0.0037	CbGpPWpGaD
Nalbuphine—Erythema—Triamcinolone—atopic dermatitis	0.00105	0.00146	CcSEcCtD
Nalbuphine—Erythema—Methylprednisolone—atopic dermatitis	0.00104	0.00146	CcSEcCtD
Nalbuphine—Asthenia—Tacrolimus—atopic dermatitis	0.00104	0.00146	CcSEcCtD
Nalbuphine—Pruritus—Tacrolimus—atopic dermatitis	0.00103	0.00144	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00103	0.00361	CbGpPWpGaD
Nalbuphine—Dysgeusia—Triamcinolone—atopic dermatitis	0.00102	0.00143	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—atopic dermatitis	0.00102	0.00143	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—atopic dermatitis	0.00102	0.00142	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00101	0.00355	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00101	0.00355	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00101	0.00355	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00101	0.00354	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Prednisolone—atopic dermatitis	0.000999	0.0014	CcSEcCtD
Nalbuphine—Vertigo—Hydrocortisone—atopic dermatitis	0.000997	0.00139	CcSEcCtD
Nalbuphine—Syncope—Hydrocortisone—atopic dermatitis	0.000996	0.00139	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000989	0.00348	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000987	0.00348	CbGpPWpGaD
Nalbuphine—Convulsion—Prednisolone—atopic dermatitis	0.000985	0.00138	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000983	0.00346	CbGpPWpGaD
Nalbuphine—Hypertension—Prednisolone—atopic dermatitis	0.000981	0.00137	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000976	0.00344	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000976	0.00136	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—atopic dermatitis	0.000966	0.00135	CcSEcCtD
Nalbuphine—Convulsion—Hydrocortisone—atopic dermatitis	0.000962	0.00134	CcSEcCtD
Nalbuphine—Dizziness—Tacrolimus—atopic dermatitis	0.00096	0.00134	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.00096	0.00338	CbGpPWpGaD
Nalbuphine—Hypertension—Hydrocortisone—atopic dermatitis	0.000958	0.00134	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000957	0.00337	CbGpPWpGaD
Nalbuphine—Erythema—Dexamethasone—atopic dermatitis	0.000948	0.00132	CcSEcCtD
Nalbuphine—Erythema—Betamethasone—atopic dermatitis	0.000948	0.00132	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—atopic dermatitis	0.000944	0.00132	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000942	0.00332	CbGpPWpGaD
Nalbuphine—Anxiety—Hydrocortisone—atopic dermatitis	0.000942	0.00132	CcSEcCtD
Nalbuphine—Vertigo—Triamcinolone—atopic dermatitis	0.000939	0.00131	CcSEcCtD
Nalbuphine—Syncope—Triamcinolone—atopic dermatitis	0.000937	0.00131	CcSEcCtD
Nalbuphine—Vertigo—Methylprednisolone—atopic dermatitis	0.000937	0.00131	CcSEcCtD
Nalbuphine—Syncope—Methylprednisolone—atopic dermatitis	0.000935	0.00131	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—atopic dermatitis	0.000928	0.0013	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000925	0.00325	CbGpPWpGaD
Nalbuphine—Vomiting—Tacrolimus—atopic dermatitis	0.000923	0.00129	CcSEcCtD
Nalbuphine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000919	0.00128	CcSEcCtD
Nalbuphine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000917	0.00128	CcSEcCtD
Nalbuphine—Rash—Tacrolimus—atopic dermatitis	0.000916	0.00128	CcSEcCtD
Nalbuphine—Dermatitis—Tacrolimus—atopic dermatitis	0.000915	0.00128	CcSEcCtD
Nalbuphine—Shock—Prednisolone—atopic dermatitis	0.000913	0.00127	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000912	0.00321	CbGpPWpGaD
Nalbuphine—Headache—Tacrolimus—atopic dermatitis	0.00091	0.00127	CcSEcCtD
Nalbuphine—Oedema—Hydrocortisone—atopic dermatitis	0.000906	0.00127	CcSEcCtD
Nalbuphine—Convulsion—Triamcinolone—atopic dermatitis	0.000906	0.00127	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—atopic dermatitis	0.000905	0.00126	CcSEcCtD
Nalbuphine—Convulsion—Methylprednisolone—atopic dermatitis	0.000904	0.00126	CcSEcCtD
Nalbuphine—Hypertension—Triamcinolone—atopic dermatitis	0.000902	0.00126	CcSEcCtD
Nalbuphine—Hypertension—Methylprednisolone—atopic dermatitis	0.0009	0.00126	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000897	0.00125	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000894	0.00315	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000892	0.00314	CbGpPWpGaD
Nalbuphine—Shock—Hydrocortisone—atopic dermatitis	0.000891	0.00125	CcSEcCtD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000889	0.00313	CbGpPWpGaD
Nalbuphine—Anxiety—Methylprednisolone—atopic dermatitis	0.000885	0.00124	CcSEcCtD
Nalbuphine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000884	0.00124	CcSEcCtD
Nalbuphine—Flushing—Prednisone—atopic dermatitis	0.000881	0.00123	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000876	0.00308	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000876	0.00308	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000876	0.00122	CcSEcCtD
Nalbuphine—Dry mouth—Triamcinolone—atopic dermatitis	0.00087	0.00122	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000867	0.00305	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000866	0.00305	CbGpPWpGaD
Nalbuphine—Nausea—Tacrolimus—atopic dermatitis	0.000863	0.00121	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000862	0.00303	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000859	0.00302	CbGpPWpGaD
Nalbuphine—Confusional state—Methylprednisolone—atopic dermatitis	0.000858	0.0012	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000856	0.00301	CbGpPWpGaD
Nalbuphine—Oedema—Triamcinolone—atopic dermatitis	0.000853	0.00119	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000853	0.003	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000853	0.003	CbGpPWpGaD
Nalbuphine—Vertigo—Dexamethasone—atopic dermatitis	0.000852	0.00119	CcSEcCtD
Nalbuphine—Vertigo—Betamethasone—atopic dermatitis	0.000852	0.00119	CcSEcCtD
Nalbuphine—Syncope—Dexamethasone—atopic dermatitis	0.000851	0.00119	CcSEcCtD
Nalbuphine—Syncope—Betamethasone—atopic dermatitis	0.000851	0.00119	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00085	0.00299	CbGpPWpGaD
Nalbuphine—Hypotension—Hydrocortisone—atopic dermatitis	0.000847	0.00118	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000842	0.00296	CbGpPWpGaD
Nalbuphine—Shock—Triamcinolone—atopic dermatitis	0.000839	0.00117	CcSEcCtD
Nalbuphine—Shock—Methylprednisolone—atopic dermatitis	0.000837	0.00117	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000836	0.00294	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Betamethasone—atopic dermatitis	0.000834	0.00116	CcSEcCtD
Nalbuphine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000834	0.00116	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—atopic dermatitis	0.000833	0.00116	CcSEcCtD
Nalbuphine—Tachycardia—Triamcinolone—atopic dermatitis	0.000833	0.00116	CcSEcCtD
Nalbuphine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000831	0.00116	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000826	0.00291	CbGpPWpGaD
Nalbuphine—Erythema—Prednisone—atopic dermatitis	0.000826	0.00115	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000825	0.00291	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000825	0.00115	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000824	0.0029	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000823	0.00115	CcSEcCtD
Nalbuphine—Convulsion—Dexamethasone—atopic dermatitis	0.000822	0.00115	CcSEcCtD
Nalbuphine—Convulsion—Betamethasone—atopic dermatitis	0.000822	0.00115	CcSEcCtD
Nalbuphine—Hypertension—Dexamethasone—atopic dermatitis	0.000819	0.00114	CcSEcCtD
Nalbuphine—Hypertension—Betamethasone—atopic dermatitis	0.000819	0.00114	CcSEcCtD
Nalbuphine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000814	0.00114	CcSEcCtD
Nalbuphine—Anxiety—Dexamethasone—atopic dermatitis	0.000805	0.00112	CcSEcCtD
Nalbuphine—Anxiety—Betamethasone—atopic dermatitis	0.000805	0.00112	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.0008	0.00281	CbGpPWpGaD
Nalbuphine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000798	0.00111	CcSEcCtD
Nalbuphine—Hypotension—Methylprednisolone—atopic dermatitis	0.000795	0.00111	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000785	0.00276	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000781	0.00275	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00078	0.00275	CbGpPWpGaD
Nalbuphine—Vision blurred—Prednisone—atopic dermatitis	0.000778	0.00109	CcSEcCtD
Nalbuphine—Oedema—Dexamethasone—atopic dermatitis	0.000774	0.00108	CcSEcCtD
Nalbuphine—Oedema—Betamethasone—atopic dermatitis	0.000774	0.00108	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000768	0.0027	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000768	0.0027	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000768	0.0027	CbGpPWpGaD
Nalbuphine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000766	0.00107	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000764	0.00107	CcSEcCtD
Nalbuphine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000764	0.00107	CcSEcCtD
Nalbuphine—Shock—Betamethasone—atopic dermatitis	0.000762	0.00106	CcSEcCtD
Nalbuphine—Shock—Dexamethasone—atopic dermatitis	0.000762	0.00106	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000761	0.00106	CcSEcCtD
Nalbuphine—Agitation—Prednisone—atopic dermatitis	0.000759	0.00106	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000755	0.00266	CbGpPWpGaD
Nalbuphine—Tachycardia—Betamethasone—atopic dermatitis	0.000755	0.00106	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—atopic dermatitis	0.000755	0.00106	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000753	0.00265	CbGpPWpGaD
Nalbuphine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000751	0.00105	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.00075	0.00264	CbGpPWpGaD
Nalbuphine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000749	0.00105	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000748	0.00105	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000748	0.00105	CcSEcCtD
Nalbuphine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000747	0.00104	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—atopic dermatitis	0.000742	0.00104	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000741	0.00103	CcSEcCtD
Nalbuphine—Syncope—Prednisone—atopic dermatitis	0.000741	0.00103	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—atopic dermatitis	0.000737	0.00103	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000732	0.00258	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000728	0.00256	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Prednisone—atopic dermatitis	0.000726	0.00101	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000724	0.00255	CbGpPWpGaD
Nalbuphine—Hypotension—Dexamethasone—atopic dermatitis	0.000723	0.00101	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—atopic dermatitis	0.000723	0.00101	CcSEcCtD
Nalbuphine—Urticaria—Hydrocortisone—atopic dermatitis	0.00072	0.00101	CcSEcCtD
Nalbuphine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000716	0.001	CcSEcCtD
Nalbuphine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000716	0.001	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—atopic dermatitis	0.000716	0.001	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—atopic dermatitis	0.000713	0.000996	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000712	0.0025	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000707	0.00249	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000703	0.000982	CcSEcCtD
Nalbuphine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000701	0.00098	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—atopic dermatitis	0.000701	0.000979	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000698	0.00246	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000696	0.000972	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—atopic dermatitis	0.000695	0.000971	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000695	0.000971	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000694	0.00244	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000688	0.00242	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000683	0.000955	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—atopic dermatitis	0.000681	0.000952	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000681	0.000952	CcSEcCtD
Nalbuphine—Urticaria—Triamcinolone—atopic dermatitis	0.000678	0.000947	CcSEcCtD
Nalbuphine—Urticaria—Methylprednisolone—atopic dermatitis	0.000676	0.000945	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000676	0.00238	CbGpPWpGaD
Nalbuphine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000674	0.000942	CcSEcCtD
Nalbuphine—Oedema—Prednisone—atopic dermatitis	0.000674	0.000942	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000673	0.00237	CbGpPWpGaD
Nalbuphine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000673	0.00094	CcSEcCtD
Nalbuphine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000668	0.000932	CcSEcCtD
Nalbuphine—Shock—Prednisone—atopic dermatitis	0.000663	0.000926	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000659	0.00232	CbGpPWpGaD
Nalbuphine—Tachycardia—Prednisone—atopic dermatitis	0.000658	0.000919	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000652	0.00091	CcSEcCtD
Nalbuphine—Asthenia—Hydrocortisone—atopic dermatitis	0.00065	0.000908	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000649	0.00229	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000649	0.00229	CbGpPWpGaD
Nalbuphine—Pruritus—Hydrocortisone—atopic dermatitis	0.000641	0.000895	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000638	0.000891	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000638	0.000891	CcSEcCtD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000637	0.00224	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000637	0.00224	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000634	0.00223	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000633	0.000884	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000633	0.000884	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000629	0.000878	CcSEcCtD
Nalbuphine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000627	0.000876	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00062	0.00218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000619	0.00218	CbGpPWpGaD
Nalbuphine—Urticaria—Betamethasone—atopic dermatitis	0.000615	0.000859	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—atopic dermatitis	0.000615	0.000859	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—atopic dermatitis	0.000613	0.000857	CcSEcCtD
Nalbuphine—Asthenia—Triamcinolone—atopic dermatitis	0.000612	0.000855	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—atopic dermatitis	0.000612	0.000855	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000612	0.000855	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000612	0.000855	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—atopic dermatitis	0.000612	0.000855	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000612	0.00215	CbGpPWpGaD
Nalbuphine—Asthenia—Methylprednisolone—atopic dermatitis	0.000611	0.000853	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.00061	0.00215	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000609	0.00214	CbGpPWpGaD
Nalbuphine—Paraesthesia—Prednisone—atopic dermatitis	0.000605	0.000846	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—atopic dermatitis	0.000604	0.000843	CcSEcCtD
Nalbuphine—Pruritus—Methylprednisolone—atopic dermatitis	0.000602	0.000841	CcSEcCtD
Nalbuphine—Dizziness—Hydrocortisone—atopic dermatitis	0.000599	0.000837	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000598	0.0021	CbGpPWpGaD
Nalbuphine—Dyspepsia—Prednisone—atopic dermatitis	0.000593	0.000829	CcSEcCtD
Nalbuphine—Rash—Prednisolone—atopic dermatitis	0.000585	0.000817	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—atopic dermatitis	0.000584	0.000816	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000582	0.00205	CbGpPWpGaD
Nalbuphine—Headache—Prednisolone—atopic dermatitis	0.000581	0.000812	CcSEcCtD
Nalbuphine—Vomiting—Hydrocortisone—atopic dermatitis	0.000576	0.000805	CcSEcCtD
Nalbuphine—Rash—Hydrocortisone—atopic dermatitis	0.000571	0.000798	CcSEcCtD
Nalbuphine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000571	0.000797	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000569	0.002	CbGpPWpGaD
Nalbuphine—Headache—Hydrocortisone—atopic dermatitis	0.000568	0.000793	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000567	0.002	CbGpPWpGaD
Nalbuphine—Dizziness—Triamcinolone—atopic dermatitis	0.000564	0.000788	CcSEcCtD
Nalbuphine—Dizziness—Methylprednisolone—atopic dermatitis	0.000563	0.000786	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000559	0.00197	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Prednisone—atopic dermatitis	0.000556	0.000776	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000555	0.00196	CbGpPWpGaD
Nalbuphine—Asthenia—Dexamethasone—atopic dermatitis	0.000555	0.000776	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—atopic dermatitis	0.000555	0.000776	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000551	0.00077	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—atopic dermatitis	0.000551	0.00077	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—atopic dermatitis	0.000548	0.000765	CcSEcCtD
Nalbuphine—Pruritus—Dexamethasone—atopic dermatitis	0.000548	0.000765	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000543	0.00191	CbGpPWpGaD
Nalbuphine—Vomiting—Triamcinolone—atopic dermatitis	0.000542	0.000758	CcSEcCtD
Nalbuphine—Vomiting—Methylprednisolone—atopic dermatitis	0.000541	0.000756	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000539	0.0019	CbGpPWpGaD
Nalbuphine—Nausea—Hydrocortisone—atopic dermatitis	0.000538	0.000752	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—atopic dermatitis	0.000538	0.000751	CcSEcCtD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000538	0.00189	CbGpPWpGaD
Nalbuphine—Dermatitis—Triamcinolone—atopic dermatitis	0.000537	0.000751	CcSEcCtD
Nalbuphine—Rash—Methylprednisolone—atopic dermatitis	0.000537	0.00075	CcSEcCtD
Nalbuphine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000536	0.000749	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—atopic dermatitis	0.000536	0.000748	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000535	0.00188	CbGpPWpGaD
Nalbuphine—Headache—Triamcinolone—atopic dermatitis	0.000534	0.000747	CcSEcCtD
Nalbuphine—Headache—Methylprednisolone—atopic dermatitis	0.000533	0.000745	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—atopic dermatitis	0.000533	0.000744	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—atopic dermatitis	0.000533	0.000744	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000524	0.00185	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000524	0.00184	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000515	0.00181	CbGpPWpGaD
Nalbuphine—Dizziness—Dexamethasone—atopic dermatitis	0.000512	0.000715	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—atopic dermatitis	0.000512	0.000715	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—atopic dermatitis	0.000507	0.000708	CcSEcCtD
Nalbuphine—Nausea—Methylprednisolone—atopic dermatitis	0.000506	0.000706	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000506	0.00178	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000504	0.00178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000497	0.00175	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Prednisone—atopic dermatitis	0.000497	0.000694	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000495	0.00174	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000495	0.00174	CbGpPWpGaD
Nalbuphine—Vomiting—Dexamethasone—atopic dermatitis	0.000492	0.000687	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—atopic dermatitis	0.000492	0.000687	CcSEcCtD
Nalbuphine—Rash—Betamethasone—atopic dermatitis	0.000488	0.000682	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—atopic dermatitis	0.000488	0.000682	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—atopic dermatitis	0.000488	0.000681	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—atopic dermatitis	0.000488	0.000681	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000487	0.00171	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000486	0.00171	CbGpPWpGaD
Nalbuphine—Headache—Betamethasone—atopic dermatitis	0.000485	0.000677	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—atopic dermatitis	0.000485	0.000677	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—atopic dermatitis	0.000484	0.000676	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000482	0.0017	CbGpPWpGaD
Nalbuphine—Pruritus—Prednisone—atopic dermatitis	0.000477	0.000666	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000472	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000472	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000472	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.00046	0.00162	CbGpPWpGaD
Nalbuphine—Nausea—Dexamethasone—atopic dermatitis	0.00046	0.000642	CcSEcCtD
Nalbuphine—Nausea—Betamethasone—atopic dermatitis	0.00046	0.000642	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000459	0.00161	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000453	0.0016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000452	0.00159	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.00045	0.00158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.00045	0.00158	CbGpPWpGaD
Nalbuphine—Dizziness—Prednisone—atopic dermatitis	0.000446	0.000623	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000443	0.00156	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000443	0.00156	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000442	0.00156	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000441	0.00155	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000434	0.00153	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000434	0.00153	CbGpPWpGaD
Nalbuphine—Vomiting—Prednisone—atopic dermatitis	0.000429	0.000599	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000428	0.00151	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000426	0.0015	CbGpPWpGaD
Nalbuphine—Rash—Prednisone—atopic dermatitis	0.000425	0.000594	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—atopic dermatitis	0.000425	0.000593	CcSEcCtD
Nalbuphine—Headache—Prednisone—atopic dermatitis	0.000422	0.00059	CcSEcCtD
Nalbuphine—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.00042	0.00148	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000418	0.00147	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000412	0.00145	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000404	0.00142	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000404	0.00142	CbGpPWpGaD
Nalbuphine—Nausea—Prednisone—atopic dermatitis	0.0004	0.000559	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000399	0.0014	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000399	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.000398	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000394	0.00139	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000394	0.00139	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000392	0.00138	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000387	0.00136	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000375	0.00132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000375	0.00132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000374	0.00132	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000367	0.00129	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000367	0.00129	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000366	0.00129	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000366	0.00129	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000366	0.00129	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00036	0.00127	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000356	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000354	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000344	0.00121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000344	0.00121	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000341	0.0012	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000338	0.00119	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000336	0.00118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000333	0.00117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000333	0.00117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000327	0.00115	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000326	0.00115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000321	0.00113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000321	0.00113	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000317	0.00112	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000312	0.0011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.00031	0.00109	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	0.000307	0.00108	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000304	0.00107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	0.000301	0.00106	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.0003	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	0.000298	0.00105	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000296	0.00104	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000291	0.00102	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000286	0.001	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	0.000276	0.000973	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.000271	0.000954	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.000271	0.000954	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	0.000269	0.000947	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000267	0.000939	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	0.000266	0.000935	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NPS—atopic dermatitis	0.000266	0.000935	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000264	0.00093	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	0.000261	0.00092	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	0.00026	0.000917	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000255	0.000896	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.00025	0.000881	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL5—atopic dermatitis	0.000247	0.000869	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	0.000242	0.000853	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000241	0.000849	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	0.000233	0.00082	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NPS—atopic dermatitis	0.000233	0.00082	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	0.000228	0.000804	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	0.000227	0.0008	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000226	0.000794	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	0.000221	0.000777	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL5—atopic dermatitis	0.000217	0.000762	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	0.000211	0.000741	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	0.000205	0.000721	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPS—atopic dermatitis	0.000197	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	0.000197	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	0.000193	0.000679	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	0.000185	0.00065	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000184	0.000648	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL5—atopic dermatitis	0.000183	0.000644	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	0.000181	0.000638	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	0.000176	0.000619	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NGF—atopic dermatitis	0.000168	0.000591	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000167	0.000588	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	0.000163	0.000575	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000161	0.000568	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	0.00016	0.000562	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	0.000159	0.000559	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	0.000156	0.000549	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	0.000154	0.000543	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGF—atopic dermatitis	0.000147	0.000518	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000147	0.000516	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	0.000143	0.000504	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	0.00014	0.000493	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000138	0.000487	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000136	0.00048	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	0.000134	0.000473	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	0.00013	0.000459	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGF—atopic dermatitis	0.000124	0.000438	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000124	0.000436	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000121	0.000427	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	0.000121	0.000426	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	0.000118	0.000417	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000103	0.000361	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	9.87e-05	0.000347	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—atopic dermatitis	9.43e-05	0.000332	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	9.39e-05	0.00033	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	8.68e-05	0.000306	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	8.66e-05	0.000305	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—atopic dermatitis	8.27e-05	0.000291	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	8.23e-05	0.00029	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	7.61e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	7.32e-05	0.000257	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—atopic dermatitis	6.99e-05	0.000246	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	6.96e-05	0.000245	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	6.43e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—atopic dermatitis	5.54e-05	0.000195	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—atopic dermatitis	4.86e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—atopic dermatitis	4.11e-05	0.000145	CbGpPWpGaD
